Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States

By sjmartinez • May 6, 2025

Nambiar P, Liang T, Labo N, Hand J, Blumberg EA, Rana MM, Florman S, Haydel B, Morris MI, Schaenman J, Rodrigues MMS, Werbel WA, Bowring MG, Friedman-Moraco RJ, Stock P, Stosor V, Mehta S, Gilbert AJ, Elias N, Mehta SA, Small CB, Haidar G, Malinis M, Pereira MR, Aslam S, Wojciechowski D, La Hoz R, Santos CAQ, Apewokin S, Castillo-Lugo JA, Ranganna K, Morsheimer M, Massie A, Segev DL, Miley W, Marshall V, Whitby D, Tobian AAA, Durand CM. Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States. Clin Infect Dis. 2025 May 5:ciaf229. doi: 10.1093/cid/ciaf229. Epub ahead of print. PMID: 40324947.

Tags: HHV8 seroprevalence, HIV, HOPE Act, Human Herpesvirus 8, Infectious Diseases, Kaposi sarcoma, KSHV seroprevalence, Organ transplantation, Publications

Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles

Moucheraud C, Trujillo D, Wagner Z, Garland W, Smith T, Hoffman RM, Landovitz RJ. Preferences for HIV prevention conditional cash transfers among Black/African American and[...]

PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town

Pike C, Rousseau E, Macdonald P, Mapukata P, Lebelo K, Joseph-Davey D, Little F, Bekker LG. PrEPared to choose: the protocol for an implementation study[...]

The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis

Martinez L, Campbell JI, Linde L, Boulahbal F, Cayla JA, Chakhaia T, Chan PC, Chen C, Fang CT, Fox G, Grandjean L, Hannoun D, Hesseling[...]